Volume 2 Supplement 1
Current trends in leukemia, lymphoma, myeloma and ITP: updates and highlights from ASH 2008
Meeting abstracts
Edited by Delong Liu
Current trends in leukemia, lymphoma and myeloma.
White Plains, NY, USA31 January 2009
-
Citation: Journal of Hematology & Oncology 2009 2(Suppl 1):I1
-
Molecular target therapy – towards curative regimen: a 20-year experience in the treatment of acute promyelocytic leukemia (APL) in the Shanghai Institute of Hematology
Citation: Journal of Hematology & Oncology 2009 2(Suppl 1):A1 -
Update of recent studies in chronic myeloid leukemia
Citation: Journal of Hematology & Oncology 2009 2(Suppl 1):A2 -
New insights on low-grade and T-cell lymphoma
Citation: Journal of Hematology & Oncology 2009 2(Suppl 1):A3 -
Recent progress in the treatment of multiple myeloma: updates and highlights from ASH 2008
Citation: Journal of Hematology & Oncology 2009 2(Suppl 1):A4 -
Update on chronic immune thrombocytopenic purpura (ITP)
Citation: Journal of Hematology & Oncology 2009 2(Suppl 1):A5
-
Official journal of
-
Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Instructions for authors
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
2022 Citation Impact
28.5 - 2-year Impact Factor
23.1 - 5-year Impact Factor
4.045 - SNIP (Source Normalized Impact per Paper)
6.046 - SJR (SCImago Journal Rank)2023 Speed
5 days submission to first editorial decision for all manuscripts (Median)
59 days submission to accept (Median)2023 Usage
3,173,795 downloads
2,671 Altmetric mentions
On the blog
-
-
Winners of the 2022 Cardio-Oncology Journal Prize
06 April 2023
-
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).